First Time Loading...

Shanghai Rongtai Health Technology Corp Ltd
SSE:603579

Watchlist Manager
Shanghai Rongtai Health Technology Corp Ltd Logo
Shanghai Rongtai Health Technology Corp Ltd
SSE:603579
Watchlist
Price: 22.93 CNY 0.39% Market Closed
Updated: Apr 28, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

344.3m
+41%
Operating Cash Flow
Growth Rates:
1 Year
+45%
3 Years
+25%
5 Years
+32%
7 Years
+96%
10 Years
-
121m
Investing Cash Flow
Growth Rates:
1 Year
-
3 Years
-
5 Years
-
7 Years
-
10 Years
-
-426.2m
-37%
Financing Cash Flow
Growth Rates:
1 Year
-
3 Years
-
5 Years
-188%
7 Years
-
10 Years
-

Cash Flow Statement
Shanghai Rongtai Health Technology Corp Ltd

Rotate your device to view
Cash Flow Statement
Currency: CNY
Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023
Operating Cash Flow
Cash Taxes Paid
61
41
34
31
33
19
24
16
16
16
(3)
(25)
(20)
(14)
(8)
15
25
23
42
52
40
70
72
68
63
62
50
50
38
(8)
(27)
Change in Working Capital
(334)
(267)
(303)
(344)
(376)
(427)
(456)
(476)
(572)
(590)
(551)
(584)
(455)
(391)
(472)
(421)
(445)
(462)
(378)
(388)
(443)
(477)
(410)
(418)
(352)
(318)
(344)
(336)
(332)
(345)
(349)
Cash from Operating Activities
281
N/A
203
-28%
176
-13%
241
+37%
220
-9%
226
+2%
281
+25%
298
+6%
307
+3%
278
-9%
261
-6%
346
+32%
359
+4%
443
+23%
447
+1%
79
-82%
134
+70%
210
+57%
276
+31%
562
+104%
542
-4%
259
-52%
338
+31%
252
-26%
248
-1%
427
+72%
237
-45%
285
+20%
302
+6%
244
-19%
344
+41%
Investing Cash Flow
Capital Expenditures
(82)
(71)
(84)
(89)
(114)
(141)
(159)
(149)
(154)
(102)
(131)
(124)
(97)
(221)
(161)
(236)
(229)
(152)
(190)
(141)
(151)
(123)
(141)
(153)
(143)
(151)
(101)
(62)
(66)
(93)
(90)
Other Items
0
(17)
1
(4)
2
4
(260)
(469)
(292)
(863)
117
(274)
18
286
(234)
277
131
279
(407)
(422)
(562)
(561)
76
339
(17)
80
(124)
(190)
(71)
(53)
211
Cash from Investing Activities
(82)
N/A
(87)
-6%
(83)
+5%
(93)
-13%
(112)
-20%
(138)
-22%
(419)
-204%
(617)
-47%
(445)
+28%
(965)
-117%
(14)
+99%
(398)
-2 825%
(79)
+80%
65
N/A
(396)
N/A
41
N/A
(98)
N/A
127
N/A
(597)
N/A
(563)
+6%
(713)
-27%
(684)
+4%
(65)
+90%
186
N/A
(160)
N/A
(71)
+56%
(225)
-218%
(252)
-12%
(137)
+46%
(146)
-7%
121
N/A
Financing Cash Flow
Net Issuance of Debt
63
118
217
222
75
10
(85)
(31)
142
209
2
(85)
(205)
(307)
(122)
51
15
(30)
564
0
0
0
115
249
229
346
294
13
(24)
(217)
(280)
Cash Paid for Dividends
(68)
(42)
(70)
(33)
(76)
(76)
(50)
(49)
(78)
(128)
(123)
(123)
(93)
(43)
(47)
(45)
(208)
(207)
(207)
0
(68)
(68)
(72)
(74)
(102)
(104)
(104)
(104)
(78)
(76)
(78)
Other
(3)
0
0
732
741
732
732
0
(33)
(22)
(27)
0
(41)
(104)
(98)
(97)
(58)
(1)
1
(10)
(13)
(25)
(69)
0
(56)
(43)
(3)
0
(20)
(20)
(68)
Cash from Financing Activities
(8)
N/A
76
N/A
148
+96%
922
+524%
740
-20%
666
-10%
597
-10%
(80)
N/A
31
N/A
60
+93%
(148)
N/A
(234)
-58%
(340)
-45%
(454)
-34%
(266)
+41%
(91)
+66%
(251)
-175%
(237)
+5%
358
N/A
192
-46%
413
+115%
501
+21%
(26)
N/A
117
N/A
72
-39%
199
+178%
188
-6%
(94)
N/A
(121)
-28%
(312)
-158%
(426)
-37%
Change in Cash
Effect of Foreign Exchange Rates
17
11
24
22
8
(8)
(32)
(41)
(25)
(0)
(2)
7
7
(2)
5
10
4
(17)
(29)
(29)
(34)
(21)
(17)
(21)
(3)
9
21
19
16
32
10
Net Change in Cash
208
N/A
202
-3%
265
+31%
1 091
+312%
856
-22%
747
-13%
428
-43%
(440)
N/A
(133)
+70%
(627)
-372%
98
N/A
(280)
N/A
(53)
+81%
51
N/A
(210)
N/A
39
N/A
(212)
N/A
82
N/A
7
-92%
162
+2 287%
209
+29%
56
-73%
229
+309%
534
+133%
157
-71%
564
+260%
221
-61%
(42)
N/A
60
N/A
(182)
N/A
49
N/A
Free Cash Flow
Free Cash Flow
199
N/A
132
-33%
92
-31%
152
+65%
106
-30%
85
-20%
123
+45%
149
+22%
153
+3%
176
+15%
131
-26%
222
+70%
263
+18%
221
-16%
285
+29%
(157)
N/A
(95)
+40%
58
N/A
86
+48%
422
+393%
391
-7%
136
-65%
196
+44%
99
-50%
105
+7%
276
+162%
136
-51%
223
+64%
236
+6%
151
-36%
255
+69%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.